Market Overview

Benzinga's Top #PreMarket Losers

Related HZNP
Watch These 6 Huge Put Purchases In Thursday Trade
Benzinga's Option Alert Recap From September 13
Related CVS
Drug Stores Next On The Amazon Hit List?
What Retailers Spend On Lobbying To Influence Trump

Horizon Pharma (NASDAQ: HZNP) fell 32.37% to $9.40 in pre-market trading after the company reported that CVS Caremark (NYSE: CVS) and Express Scripts (NASDAQ: ESRX) expect to announce DUEXIS and VIMOVO will no longer be on formularies and will be placed on exclusion lists effective january 1, 2015.

AcelRx Pharmaceuticals (NASDAQ: ACRX) shares declined 28.72% to $7.72 in pre-market trading after the company received Complete Response Letter from the FDA for New Drug Application for Zalviso.

Hanwha SolarOne Co (NASDAQ: HSOL) dipped 4.48% to $2.13 in pre-market trading after falling 0.45% on Friday. (NASDAQ: SOHU) dropped 4.21% to $55.00 in pre-market trading after the company posted a loss in the second quarter. The company posted a quarterly loss of $45 million, or $1.16 per share, versus a loss of $69 million in the earlier quarter. Non-GAAP net loss came in at US$0.88 loss per share.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (CVS + ACRX)

View Comments and Join the Discussion!